N1VS34:BVMF
Novartis AG Bdr
R$ 74.34
0.00%
(0.00) Siku 1
14 Okt, 16:56:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya N1VS34...
Fungua
R$ 80.09
Juu
R$ 80.09
Chini
R$ 73.43
Mtaji wa soko
300.82B
Wastani wa kiasi cha mauzo
201.00
Kiasi cha mauzo ya hisa
114.00
Juu kwa wiki 52
R$ 87.30
Chini kwa wiki 52
R$ 65.03
Hisa za wawekezaji
2.03B
Idadi ya wafanyakazi
elfu 75
Fungua
R$ 80.09
Juu
R$ 80.09
Chini
R$ 73.43
Mtaji wa soko
300.82B
Wastani wa kiasi cha mauzo
201.00
Kiasi cha mauzo ya hisa
114.00
Juu kwa wiki 52
R$ 87.30
Chini kwa wiki 52
R$ 65.03
Hisa za wawekezaji
2.03B
Idadi ya wafanyakazi
elfu 75
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
GuruFocus
·
saa 4 zilizopita
Novartis AG (NVS) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 68/100
Global Arbitration Review
·
saa 6 zilizopita
US biotech company enforces eye treatment award against Novartis
Quiver Quantitative
·
saa 8 zilizopita
Why Novartis (NVS) Stock Is Up Today
Investing.com Canada
·
saa 14 zilizopita
MindWalk adds three executives from Pfizer, Novartis, Arbor By Investing.com
Wasifu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Kuhusu Novartis AG Bdr
Afisa Mkuu Mtendaji (CEO)Vasant Narasimhan
Wafanyakazielfu 75.3
Lilianzishwa7 Mac 1996
Makao makuuBasel, Mji wa Basel, Uswisi
Sekta-
Tovutinovartis.com